Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer
Lei Zhong(University of Electronic Science and Technology of China), Shengyong Yang(Sichuan University)
Cited by 6
Related Papers
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
|Signal Transduction and Targeted Therapy|2021|1.6k
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
|Nature Communications|2022|98
The bromodomain protein BRD4 positively regulates necroptosis via modulating MLKL expression
|Cell Death and Differentiation|2019|39
Systems Biology Modeling Reveals a Possible Mechanism of the Tumor Cell Death upon Oncogene Inactivation in EGFR Addicted Cancers
|PLoS ONE|2011|11
Protective effect of ethyl vanillin against Aβ‑induced neurotoxicity in PC12 cells via the reduction of oxidative stress and apoptosis
|Experimental and Therapeutic Medicine|2019|8